Howard Golub

TearClear Corp. operates as an early-stage medical science company. It develops a hydrogel filter to remove potentially harmful preservatives from multi dose topical ophthalmic products used to treat chronic diseases such as glaucoma, dry-eye and allergic conjunctivitis. The company was founded by Anuj Chauhan in 2015 and is headquartered in Copley, OH.

TearClear Corp. operates as an early-stage medical science company. It develops a hydrogel filter to remove potentially harmful preservatives from multi dose topical ophthalmic products used to treat chronic diseases such as glaucoma, dry-eye and allergic conjunctivitis. The company was founded by Anuj Chauhan in 2015 and is headquartered in Copley, OH.

TearClear Corp. operates as an early-stage medical science company. It develops a hydrogel filter to remove potentially harmful preservatives from multi dose topical ophthalmic products used to treat chronic diseases such as glaucoma, dry-eye and allergic conjunctivitis. The company was founded by Anuj Chauhan in 2015 and is headquartered in Copley, OH.

TearClear Corp. operates as an early-stage medical science company. It develops a hydrogel filter to remove potentially harmful preservatives from multi dose topical ophthalmic products used to treat chronic diseases such as glaucoma, dry-eye and allergic conjunctivitis. The company was founded by Anuj Chauhan in 2015 and is headquartered in Copley, OH.

TearClear Corp. operates as an early-stage medical science company. It develops a hydrogel filter to remove potentially harmful preservatives from multi dose topical ophthalmic products used to treat chronic diseases such as glaucoma, dry-eye and allergic conjunctivitis. The company was founded by Anuj Chauhan in 2015 and is headquartered in Copley, OH.